AI drug discovery success inspires a machine-learning startup at the Mayo Clinic
A little over a year ago, Andrew Badley, the chief medical officer and new tech leader at the Mayo Clinic, thought it would be a good time to start testing the waters on artificial intelligence-driven technology for drug discovery. Working with Murali Aravamudan at nference, they put some of the latest tech on data-driven machine learning to use for one of the investigators at the Mayo Clinic who had been doing some hard thinking about a molecular target.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.